Insight into the Medicinal Chemistry of the Endocannabinoid Hydrolase Inhibitors

被引：0

作者：

Kapanda, C. N. ^{[1
]}

Poupaert, J. H. ^{[1
]}

Lambert, D. M. ^{[1
]}

机构：

[1] Catholic Univ Louvain, LDRI, Med Chem Cannabinoid & Endocannabinoid Res Grp, B-1200 Brussels, Belgium

来源：

CURRENT MEDICINAL CHEMISTRY | 2013年 / 20卷 / 14期

关键词：

Endocannabinoid hydrolases; inhibitors; design; chemical structures; inhibition mechanism; structure-activity relationships; ACID AMIDE HYDROLASE; MONOACYLGLYCEROL LIPASE INHIBITORS; CANNABINOID-RECEPTOR LIGANDS; ACTIVITY IN-VIVO; 2-ARACHIDONOYLGLYCEROL HYDROLYSIS; MOLECULAR CHARACTERIZATION; REVERSIBLE INHIBITORS; MONOGLYCERIDE LIPASE; CB1; RECEPTOR; ANANDAMIDE AMIDOHYDROLASE;

D O I：

暂无

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Endocannabinoid hydrolases are nowadays increasingly considered as potential therapeutic targets for treating several pathological states. So far, numerous classes of endocannabinoid hydrolase inhibitors have been described. We herein review the medicinal chemistry of these inhibitors with a particular emphasis on the basis of their design, chemical structure, structure-activity relationships, and inhibition mechanisms.

引用

页码：1824 / 1846

页数：23

共 139 条

[111] Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH
Rusch, Marion
Zahov, Stefan
Vetter, Ingrid R.
Lehr, Matthias
Hedberg, Christian
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (02) : 1100 - 1112
[112] Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes
Saario, SM
Salo, OMH
Nevalainen, T
Poso, A
Laitinen, JT
Järvinen, T
Niemi, R
[J]. CHEMISTRY & BIOLOGY, 2005, 12 (06): : 649 - 656
[113] Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system
Saario, Susanna M.
Poso, Antti
Juvonen, Risto O.
Jarvinen, Tomi
Salo-Ahen, Outi M. H.
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (15) : 4650 - 4656
[114] SANOFI SYNTHELABO, 2004, Patent No. 2004020430
[115] The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors
Savinainen, J. R.
Saario, S. M.
Laitinen, J. T.
[J]. ACTA PHYSIOLOGICA, 2012, 204 (02) : 267 - 276
[116] Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Schlosburg, Joel E.
Blankman, Jacqueline L.
Long, Jonathan Z.
Nomura, Daniel K.
Pan, Bin
Kinsey, Steven G.
Nguyen, Peter T.
Ramesh, Divya
Booker, Lamont
Burston, James J.
Thomas, Elizabeth A.
Selley, Dana E.
Sim-Selley, Laura J.
Liu, Qing-song
Lichtman, Aron H.
Cravatt, Benjamin F.
[J]. NATURE NEUROSCIENCE, 2010, 13 (09) : 1113 - U111
[117] Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors
Segall, Y
Quistad, GB
Nomura, DK
Casida, JE
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3301 - 3303
[118] Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors
Seierstad, Mark
Breitenbucher, J. Guy
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (23) : 7327 - 7343
[119] Novel inhibitors of fatty acid amide hydrolase
Sit, S. Y.
Conway, Charlie
Bertekap, Robert
Xie, Kai
Bourin, Clotilde
Burris, Kevin
Deng, Hongfeng
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (12) : 3287 - 3291
[120] Oxime Carbamate-Discovery of a series of novel FAAH inhibitors
Sit, S. Y.
Conway, Charles M.
Xie, Kai
Bertekap, Robert
Bourin, Clotilde
Burris, Kevin D.
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (03) : 1272 - 1277

← 5 6 7 8 9 10 11 12 13 14 →